DRTECH Surges on Return to Market; HLB Innovation, L&K Biomed Rise[K-bio pulse]

This article was released as Pharm Edaily Premium Content on September 11, 2026, at 8:40 AM.[Kim Jin Soo, Edaily Repoeter] On Sept. 10, DRTECH, which resumed trading following the completion of a reverse stock split, saw sharp swings in its share price. The medical imaging company drew investor attention as expectations grew over the global expansion of its flagship surgical C-arm systems.Shares of HLB Innovation and L&K Biomed also advanced, driven respectively by expectations for upcoming clinical data from a CAR-T therapy and a potential global distribution agreement for spinal implant products.DRTECH stock trend. (KG Zeroin)DRTECH Rises on FDA Clearance After Trading ResumesAccording to MP DOCTOR, formerly MarketPoint, operated by KG Zeroin, DRTECH hit the daily upper limit intraday on its first day of trading following the completion of its reverse stock split. The stock later gave up much of its gains and closed at KRW 5,040, up 5.00% from the previous session.Investor interest was largely attributed to U.S. Food and Drug Administration clearance for EXTRON 6, DRTECH’s premium surgical C-arm system.The EXTRON series combines DRTECH’s in-house video detectors with propriet...